Jeff Geschwind

Jeff Geschwind serves as a Medical Advisor in the Division of Medical Affairs at HistoSonics, Inc. since January 2024. From March 2019, Jeff has held the position of Director of Oncology at USA Vein Clinics and USA Fibroid Centers, while concurrently working as a Consultant for Philips and NAMSA, where Jeff is the Medical Director for the Oncology, Image-Guided Therapy, and Imaging Core Lab. Jeff founded PreScience Labs in July 2017, a bio-pharmaceutical company that achieved significant funding milestones. Previous roles include Consultant in Oncology and Business Development at Syntactx and Chairman of the Department of Radiology and Biomedical Imaging at Yale University School of Medicine and Yale New Haven Hospital. With a robust academic background, Jeff served as a Professor and Director at Johns Hopkins Medicine prior to joining Yale. Jeff holds an MD from Boston University School of Medicine and has pursued education at prestigious institutions including the University of California, San Francisco and The Johns Hopkins University School of Medicine.